ClinicalTrials.Veeva

Menu

Safety and Effectiveness of an Auricular Spray

Y

YSLab

Status

Completed

Conditions

Excessive Ear Wax

Treatments

Other: Ear Hygiene

Study type

Interventional

Funder types

Industry

Identifiers

NCT06085443
23E1670

Details and patient eligibility

About

The goal of this clinical trial is to test the safety and efficacy of a medical device in subjects with cerumen in excess. The main questions it aims to answer are:

  • Does the medical device induce skin irritation in the ear canal?
  • Does the medical device reduce obstruction of ear canal induced by excessive cerumen?

Participants will use the device in each ear, once a day, every 3 days at home. Researchers will compare the medical device group to a control group who will not use the medical device.

Full description

Ocean Bio Actif Hygiène de l'oreille is a medical device class IIa indicated for the prevention of the formation of earwax plugs and consequently the pathologies linked to the accumulation of earwax (hearing loss and infection/affection of the external auditory canal).

This clinical investigation is designed to improve the quality and quantity of data available on both the safety and the efficacy of Ocean Bio-Actif, in order to confirm the safety and the efficacy of the product in a post-market environment.

The objective of the current clinical investigation is to confirm the efficacy and safety of topical application to the ear canal of Ocean Bio-Actif.

Enrollment

99 patients

Sex

All

Ages

3+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Gender: female and/or male.

  • Age:

    30 to 40% having age between 3 to 12 yo, 30 to 40% between 13 to 65 yo, 30 to 40% more than 65 yo.

  • Subjects able to use the tested product.

  • Subjects having history of cerumen occlusion more than once a year with or without symptoms (reduction of hearing function, obstruction feeling of the ear canal,..).

  • Subjects having ear help system or regular users of systems such as anti-noise plugs or headsets (only for the 13yo subjects and more).

  • Subjects having a clinical score of ear canal obstruction of 2 or 3 at D0.

Exclusion criteria

  • Subjects who had chirurgical act on the mastoïde.
  • Subjects who had severe troubles of the internal ear (severe dizziness, desorientation, nausea).
  • Subjects using regularly a ear spray for washing his/her ears.
  • Subjects having a score of ear canal obstruction at 4 at D0.
  • Pregnant or nursing woman or planning a pregnancy during the study;
  • Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship;
  • Subject in a social or sanitary establishment;
  • Subject suspected to be non-compliant according to the investigator's judgment;
  • Subject with a condition or receiving a medication which, in the investigator's judgment, put the subject at undue risk;
  • Subject suffering from a severe or progressive disease.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

99 participants in 2 patient groups

Auricular spray
Experimental group
Description:
Subjects using the medical device under investigation: 2 sprays in each ear, every 3 days at home.
Treatment:
Other: Ear Hygiene
Control
No Intervention group
Description:
Subjects not using any spray (can use ear drops in case of discomfort or pain)

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Caroline TANTER

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems